Home
NICE Guidance
Conditions and diseases
Genetic conditions
Cystic fibrosis
OxyMask for delivering oxygen therapy
Medtech innovation briefing [MIB160]
Published date:
September 2018
Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Specialist commentator comments
Specialist commentators
Development of this briefing
Share
Share
Linked In
Twitter
Facebook
Email
More...
Download
Save
Save as PDF
Save as ePub
Save as eBook
Advice
Next
Regulatory information
Regulatory information
OxyMask is a CE marked class IIa medical device.